OA18.05LB Multivalent antigen presentation increases the antibody binding breadth and neutralizing potency upon the immunization with a self-assembling HIV env vaccineOral Abstract SessionNovel vaccine and other prevention approaches
OA19.01 Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trialOral Abstract SessionMicrobiome & STI: impact on prevention
OA19.02 Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new speciesOral Abstract SessionMicrobiome & STI: impact on prevention
OA19.03 Transcriptional analysis of cervical cell populations reveals inflammatory signatures and differential epithelial keratinization associated with Depo-Provera useOral Abstract SessionMucosal immunity
OA19.04LB Silk fibroin as a mucosal delivery vehicle for Griffithsin and antiviral compounds: effective protection of macaques and high acceptance among user groupsOral Abstract SessionDelivery technologies: novel approaches, formulation and multi-purpose
OA19.05LB Pharmacokinetic and pharmacodynamic study of tenofovir and tenofovir alafenamide for PrEP in foreskin tissueOral Abstract SessionPharmacology/PK and PD studies
OA20.01 Alternative T cell effector functions are linked to humoral responses to HIV infectionOral Abstract SessionCellular immunity
OA20.02 HIV-resistant dual CD28/4-1BB costimulated CAR T cells mitigate HIV pathogenesis in humanized miceOral Abstract SessionCellular immunity
OA20.03 Immune perturbation is more profound in newborn than in infant macaques during acute SHIV infectionOral Abstract SessionPreclinical studies for HIV prevention
OA20.04 Tissue-resident memory CD4+ T cells in ectocervical versus endocervical specimensOral Abstract SessionMucosal immunity
seek-warrow-warrow-eseek-e91 - 100 of 444 items